Literature DB >> 17363765

Procedural pain management patterns in academic pediatric emergency departments.

Rishi Bhargava1, Kelly D Young.   

Abstract

OBJECTIVES: To describe the current state of the art for pain and sedation management for five common pediatric emergency department (ED) procedure scenarios.
METHODS: Fellowship directors of U.S. EDs with a pediatric emergency medicine fellowship training program were surveyed by mail and asked to choose the one most commonly used pain or sedation management option for five clinical scenarios: facial laceration repair, cranial computed tomography in a toddler, closed fracture reduction, neonatal lumbar puncture, and intravenous catheter insertion. Results were analyzed by using descriptive statistics, and the differences between high and low volume departments were compared by using a chi-square test.
RESULTS: Thirty-eight of 51 fellowship programs responded (75%). The majority of respondents were fellowship directors (76%). Topical anesthetics were most commonly reported as used for a simple facial laceration (84%), whereas ketamine sedation was most popular for fracture reduction (86%). Pain management for the other scenarios was more variable. More than half of the respondents (53%) would not sedate at all for cranial computed tomography, and only 38% reported use of pharmacologic pain management for intravenous catheter insertion. The majority (74%) reported use of anesthetic (topical or injected local) for neonatal lumbar puncture. High volume departments were more likely to use pain management for intravenous catheter insertions.
CONCLUSIONS: Pain and sedation management methods for pediatric procedures continue to evolve. Despite gains, there is still room for improvement, particularly regarding intravenous catheter insertions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17363765     DOI: 10.1197/j.aem.2006.12.006

Source DB:  PubMed          Journal:  Acad Emerg Med        ISSN: 1069-6563            Impact factor:   3.451


  8 in total

1.  Protective function of nicotinamide against ketamine-induced apoptotic neurodegeneration in the infant rat brain.

Authors:  Najeeb Ullah; Ikram Ullah; Hae Young Lee; Muhammad Imran Naseer; Park Moon Seok; Jawad Ahmed; Myeong Ok Kim
Journal:  J Mol Neurosci       Date:  2011-12-08       Impact factor: 3.444

2.  Pediatric procedural pain: how far have we come? An ethnographic account.

Authors:  Jo Ann F Cummings
Journal:  Pain Manag Nurs       Date:  2015-06       Impact factor: 1.929

3.  Efficacy of pain control with topical lidocaine-epinephrine-tetracaine during laceration repair with tissue adhesive in children: a randomized controlled trial.

Authors:  Stuart Harman; Roger Zemek; Mary Jean Duncan; Yvonne Ying; William Petrcich
Journal:  CMAJ       Date:  2013-07-29       Impact factor: 8.262

4.  Comforting strategies and perceived barriers to pediatric pain management during IV line insertion procedure in Uganda's national referral hospital: A descriptive study.

Authors:  Godfrey Katende; Benedicto Mugabi
Journal:  BMC Pediatr       Date:  2015-09-16       Impact factor: 2.125

5.  A comparison of pain assessment by physicians, parents and children in an outpatient setting.

Authors:  Christina Brudvik; Svein-Denis Moutte; Valborg Baste; Tone Morken
Journal:  Emerg Med J       Date:  2016-10-25       Impact factor: 2.740

Review 6.  Intranasal ketamine for procedural sedation and analgesia in children: A systematic review.

Authors:  Naveen Poonai; Kyle Canton; Samina Ali; Shawn Hendrikx; Amit Shah; Michael Miller; Gary Joubert; Michael Rieder; Lisa Hartling
Journal:  PLoS One       Date:  2017-03-20       Impact factor: 3.240

7.  The influence of an accredited pediatric emergency medicine program on the management of pediatric pain and anxiety.

Authors:  Tali Capua; Zohar Bar Kama; Ayelet Rimon
Journal:  Isr J Health Policy Res       Date:  2018-03-21

Review 8.  Ketamine: 50 Years of Modulating the Mind.

Authors:  Linda Li; Phillip E Vlisides
Journal:  Front Hum Neurosci       Date:  2016-11-29       Impact factor: 3.169

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.